Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma
- PMID: 27222020
- DOI: 10.1007/s11604-016-0555-1
Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma
Abstract
Positron emission tomography/computed tomography (PET/CT) integrated with 2-[(18)F]fluoro-2-deoxy-D-glucose ((18)F-FDG) has emerged as a powerful tool for combined metabolic and anatomic evaluations in clinical oncologic imaging. This review discusses the utility of (18)F-FDG PET/CT as a tool to manage patients with malignant pleural mesothelioma. We discuss different stages of patient management in malignant pleural mesothelioma, including diagnosis, initial staging, therapy planning, early treatment response assessment, re-staging, and prognosis.
Keywords: Diagnosis; Fluorodeoxyglucose (FDG); Malignant pleural mesothelioma; Positron emission tomography/computed tomography (PET/CT); Prognosis; Re-staging; Staging; Treatment response assessment.
Similar articles
-
Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.AJR Am J Roentgenol. 2019 Feb;212(2):311-319. doi: 10.2214/AJR.18.20111. Epub 2018 Dec 4. AJR Am J Roentgenol. 2019. PMID: 30512992
-
Present and future roles of FDG-PET/CT imaging in the management of lung cancer.Jpn J Radiol. 2016 Jun;34(6):387-99. doi: 10.1007/s11604-016-0546-2. Epub 2016 Apr 27. Jpn J Radiol. 2016. PMID: 27121156 Review.
-
Histology of the pleural rind at [18F]FDG PET/CT hot and cold spots in mesothelioma patients after talc pleurodesis and neoadjuvant chemotherapy.Pathol Res Pract. 2021 Dec;228:153660. doi: 10.1016/j.prp.2021.153660. Epub 2021 Oct 19. Pathol Res Pract. 2021. PMID: 34749212
-
Malignant pleural mesothelioma: utility of 18 F-FDG PET.Ann Ital Chir. 2007 Sep-Oct;78(5):393-6. Ann Ital Chir. 2007. PMID: 18338546 Review.
-
Pleural tuberculosis mimicking malignant pleural mesothelioma by 18F-FDG PET/CT.Med Clin (Barc). 2023 Nov 10;161(9):415. doi: 10.1016/j.medcli.2023.04.019. Epub 2023 May 30. Med Clin (Barc). 2023. PMID: 37263842 English, Spanish. No abstract available.
Cited by
-
Fluorodeoxyglucose versus Choline Positron Emission Tomography/Computed Tomography Response Evaluation in Two Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Neoadjuvant Chemotherapy.Cureus. 2018 Nov 28;10(11):e3654. doi: 10.7759/cureus.3654. Cureus. 2018. PMID: 30723653 Free PMC article.
-
A Case of Pulmonary Embolism with Sarcomatoid Malignant Pleural Mesothelioma with Long-Term Pleural Effusion.Onco Targets Ther. 2021 Jul 16;14:4231-4237. doi: 10.2147/OTT.S315869. eCollection 2021. Onco Targets Ther. 2021. PMID: 34295165 Free PMC article.
-
The Prognostic Value of 18F-FDG PET Imaging at Staging in Patients with Malignant Pleural Mesothelioma: A Literature Review.J Clin Med. 2021 Dec 22;11(1):33. doi: 10.3390/jcm11010033. J Clin Med. 2021. PMID: 35011772 Free PMC article. Review.
-
Clinical staging of malignant pleural mesothelioma: current perspectives.Lung Cancer (Auckl). 2017 Aug 18;8:127-139. doi: 10.2147/LCTT.S102113. eCollection 2017. Lung Cancer (Auckl). 2017. PMID: 28860886 Free PMC article. Review.
-
Implementing CT tumor volume and CT pleural thickness into future staging systems for malignant pleural mesothelioma.Cancer Imaging. 2021 Aug 3;21(1):48. doi: 10.1186/s40644-021-00415-5. Cancer Imaging. 2021. PMID: 34344472 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical